{
    "2021-09-03": [
        [
            {
                "time": "",
                "original_text": "国信证券：维持华兰生物(002007.SZ)“买入”评级 业绩略低于预期 血制品板块维持稳健",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "买入评级",
                        "业绩略低于预期",
                        "血制品板块",
                        "稳健"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "血制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "国信证券给维持华兰生物买入评级，2021半年报点评：业绩略低于预期，长期逻辑不改",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "买入评级",
                        "2021半年报",
                        "业绩略低于预期",
                        "长期逻辑不改"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}